Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/21645515.2021.1923350 http://scihub22266oqcxt.onion/10.1080/21645515.2021.1923350 34161189!8240541!34161189     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=34161189&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Hum+Vaccin+Immunother 2021 ; 17 (10): 3491-3494 Nephropedia Template TP {{tp|p=34161189|t=2021. Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies |pdf=|usr=}}{{34161189}} gab.com Text Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies JO: Hum Vaccin Immunother http://www.kidney.de/pget.php?&tw=1&pmid=34161189 #FOAvip The genetic variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been emerging and circulating in different parts of the world from the beginning of the coronavirus disease (COVID-19) pandemic. Variants are divided into three classes: variant of interest, variant of concern, and variant of high consequence depending on its impact on the transmission, disease severity, diagnostics, vaccines, and therapeutics. The variants of concern include the United Kingdom variant (B.1.1.7), South Africa variant (B.1.351), two related California variants (B.1.427 and B.1.429), and Brazil variant (P.1). These SARS-CoV-2 variants have a direct impact on the available COVID-19 vaccines and immunotherapeutics as they can alter the neutralizing activity of vaccine-elicited antibodies and monoclonal antibodies resulting in mild-to-substantial loss of efficacy. There is a need to establish surveillance systems that can monitor the emergence of novel SARS-CoV-2 variants worldwide. Twit Text FOAVip Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies ????Hum Vaccin Immunother http://www.kidney.de/pget.php?&tw=1&pmid=34161189 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34161189 #FOAvip English Wikipedia <ref>{{Cite pmid|34161189}}</ref> Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutralizing antibodies #MMPMID34161189 Sharun K; Tiwari R; Dhama K; Emran TB; Rabaan AA; Al Mutair A Hum Vaccin Immunother 2021[Oct]; 17 (10): 3491-3494 PMID34161189show ga The genetic variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been emerging and circulating in different parts of the world from the beginning of the coronavirus disease (COVID-19) pandemic. Variants are divided into three classes: variant of interest, variant of concern, and variant of high consequence depending on its impact on the transmission, disease severity, diagnostics, vaccines, and therapeutics. The variants of concern include the United Kingdom variant (B.1.1.7), South Africa variant (B.1.351), two related California variants (B.1.427 and B.1.429), and Brazil variant (P.1). These SARS-CoV-2 variants have a direct impact on the available COVID-19 vaccines and immunotherapeutics as they can alter the neutralizing activity of vaccine-elicited antibodies and monoclonal antibodies resulting in mild-to-substantial loss of efficacy. There is a need to establish surveillance systems that can monitor the emergence of novel SARS-CoV-2 variants worldwide. |*Antibodies, Neutralizing[MESH] |*COVID-19[MESH] |COVID-19 Vaccines[MESH] |Humans[MESH]Emerging SARS-CoV-2 variants: impact on vaccine efficacy and neutraliz(epmc).pdf DeepDyve Pubget Overpricing